EXELExelixis Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 15073
Ticker: EXEL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2000-04-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: EXEL

Detail

Enriched 2026-08-14 20:47

Market cap: $12,483,241,642.96
Shares outstanding (class): 251,355,083
Shares outstanding (weighted): 247,781,692
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 1,077
Location: ALAMEDA, CA
Homepage: https://www.exelixis.com
Description: Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Market cap and share counts drift.

Funds holding this security

303 funds · 310 positions · $3.03B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$368.80M	0.35%	8,598,638 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$337.00M	0.02%	7,857,216 NS	FIGI
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust	—	$302.29M	2.70%	7,048,116 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$243.99M	0.15%	5,688,770 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$136.61M	0.35%	3,185,081 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$124.35M	0.15%	2,899,280 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$87.03M	1.17%	2,029,215 NS	FIGI
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$83.96M	0.35%	1,957,453 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$80.26M	0.99%	1,871,326 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$78.54M	3.46%	1,831,270 NS	FIGI
iShares S&P Mid-Cap 400 Growth ETF iShares Trust	IJK	$67.75M	0.68%	1,579,578 NS	FIGI
iShares Russell Mid-Cap Growth ETF iShares Trust	IWP	$61.47M	0.33%	1,433,164 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$54.41M	0.35%	1,268,647 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$43.30M	0.09%	1,009,472 NS	FIGI
AQR Long-Short Equity Fund AQR Funds	—	$38.59M	0.48%	899,823 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEREXEL
FIGI_COMPOSITEBBG000BQ4WF8
FIGI_SHARE_CLASSBBG001SD42W4
CIK0000939767
ISINUS30161Q1040
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Exelixis is a biopharmaceutical company developing cancer therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.